Menu

Blog

Nov 1, 2023

CRISPR, Vertex gene editing therapy gets warm response from FDA panel

Posted by in categories: bioengineering, biotech/medical

An FDA advisory panel tended to embrace a new gene therapy treatment from Vertex and CRISPR for sickle cell anemia on Tuesday.

Comments are closed.